1672. Eligibility and Outcomes of Conversion to Oral (PO) Therapy in Patients Hospitalized with Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis

BACKGROUND: Rising rates of fluoroquinolone resistance (FQ-R) and third-generation cephalosporin resistance/extended-spectrum beta-lactamases (ESBL+) have left patients with urinary tract infections (UTI) few oral options. Here, we evaluate the eligibility of hospitalized UTI patients to take PO med...

Descripción completa

Detalles Bibliográficos
Autores principales: Melnick, David, Jain, Akash, Gupta, Vikas, Sulham, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778096/
http://dx.doi.org/10.1093/ofid/ofaa439.1850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778096/
http://dx.doi.org/10.1093/ofid/ofaa439.1850

Ejemplares similares